Patricia Rosa, Ph.D.

Molecular Genetics Section

Patricia Rosa, Ph.D.

Chief, Molecular Genetics Section

Contact: For contact information, search the NIH Enterprise Directory.

Patricia Rosa, Ph.D.

Major Areas of Research

  • Development of a genetic system for Borrelia burgdorferi, the spiral-shaped bacterium that causes Lyme disease.
  • Analysis of the structure and function of the plasmid component of the highly segmented B. burgdorferi genome
  • Determination of the roles of specific plasmids, genes, and proteins during the natural infectious cycle of B. burgdorferi

Program Description

Research in this laboratory focuses primarily on Borrelia burgdorferi, the spirochete that causes Lyme disease, the most common arthropod-borne disorder in the United States. B. burgdorferi is maintained in nature through an infectious cycle between wild mammals and ticks. Occasionally, infected ticks feed upon humans and transmit the spirochete, resulting in Lyme disease.

Human infection has medical significance as a multisystemic, potentially chronic illness. The tick vector and the mammalian host represent very different environments, and there is good evidence for differential gene expression by borreliae in these locations.

The infectious cycle of B. burgdorferi

  •  B. burgdorferi spirochetes persist in a latent state in midgets of infected ticks for many months.
  •  After a tick attaches to a mammalian host and ingests a blood meal, spirochetes multiply and efficiently move to the salivary glands.
  • B. burgdorferi is then transmitted via tick saliva and remains in the mammalian skin for several days before dissemination via the bloodstream.
  • Spirochetes persist in low numbers in infected mammals yet are efficiently acquired by feeding ticks following attachment.

This scenario suggests that B. burgdorferi responds to environmental cues to adapt and move between the tick vector and mammalian host. Recent experiments document modulation of spirochetal outer surface proteins in response to environmental conditions and reinforce this hypothesis.

Our broad objective is to use a molecular genetic approach to elucidate the mechanisms of adaptation and variation in B. burgdorferi and their roles in the infectious cycle. The specific aims of our research are as follows:

1.    Develop basic genetic tools to manipulate borrelial genes of interest. The availability of the complete genomic sequence of B. burgdorferi represents a wealth of information that can be effectively utilized through a genetic approach. However, studies of the biology of B. burgdorferi and the pathogenesis of Lyme disease have been limited by a lack of genetic tools, because most methods that have been developed for other bacteria cannot be directly applied to borreliae. To address our scientific goals, we have developed and continue to add to a set of basic genetic tools for B. burgdorferi. The ability to perform routine genetic manipulations in B. burgdorferi has greatly facilitated our research objectives as well as those of other investigators in the field.

2.    Understand the structure and function of plasmids in B. burgdorferi. A distinguishing feature of the B. burgdorferigenome (fig 1. below) is the presence of a linear chromosome and multiple linear and circular plasmids. The genomic sequence of B. burgdorferi identified 21 different plasmids, representing the largest known complement of plasmids of all bacteria and constituting one-third of the spirochete’s DNA. More than 90 percent of the plasmid-encoded genes are unique to B. burgdorferi, without homologs in any other organisms, suggesting they encode functions pertinent to the distinctive lifestyle of the spirochete. We have undertaken to

  • Define the minimal plasmid elements required for replication, partitioning, and incompatibility of linear and circular replicons
  • Assess the roles of individual plasmids and specific plasmid-encoded genes for survival in, or transmission between, the tick vector and mammalian host

3.    Determine how B. burgdorferi responds to particular environmental cues in order to persist and be transmitted between the tick vector and mammalian host. We hypothesize that discrete environmental signals induce appropriate bacterial responses that are critical for survival and transmission of the spirochete during the infectious cycle. We endeavor to

  • Determine which proteins are made in different sites or at different stages of the infectious cycle in ticks and mammals
  • Determine what these proteins do and how the genes encoding them are regulated
  • Decipher the signals that mediate the adaptive responses

Knowing which bacterial proteins are synthesized in the mammal versus the tick and gaining insight into their functions will contribute to a better understanding of the pathogenesis of Lyme disease. This knowledge is relevant to the diagnosis and prevention of Lyme disease.

Figure 1:  B. burgdorferi Genome

B. burgdorferi Genome

B. burgdorferi Genome


B. burgdorferi Genome

Credit: NIAID


The transmission of B. burgdorferi between ticks and mammals represents an ideal system in which to study the adaptive responses of a bacterial pathogen to its vector and host environments. All steps of this infectious cycle can be reproduced in the laboratory, making it accessible to scientific investigation. Molecular genetics represents a powerful method with which to address this system.

Previous studies have identified spirochetal components that should be important in the adaptation of B. burgdorferi to its environment. Ongoing and future studies are designed to test the roles of these genes and their products in the infectious cycle and to identify additional genes that allow the spirochetes to adapt, persist, and be transmitted between ticks and mammals. This research should elucidate the biological basis of these bacterium-host-vector relationships and the factors that contribute to the pathogenesis of disease in an incidental human host.



Dr. Rosa received her doctorate in 1980 from the Institute of Molecular Biology at the University of Oregon. In 1988, following research fellowships at Washington University School of Medicine in St. Louis and at the Research Institute of Scripps Clinic, Dr. Rosa joined Rocky Mountain Laboratories.

Dr. Rosa became a tenured investigator in 2000. Dr. Rosa is a fellow of the American Academy of Microbiology and an internationally recognized leader in the field of bacterial molecular genetics.

Selected Publications

Takacs, C.N., Kloos, Z.A., Scott, M., Rosa, P.A., and Jacobs-Wagner, C.  Fluorescent proteins, promoters, and selectable markers for applications in the Lyme disease spirochete Borrelia burgdorferi. Appl. Environ. Microbiol. 84: e01824-18, 2018.

Hillman, C., Stewart, P.E., Strnad, M., Stone, H., Starr, T., Carmody, A., Evans, T.J., Carracoi, V., Wachter, J., and Rosa, P.A.  Visualization of spirochetes by labeling membrane proteins with fluorescent biarsenical dyes. Front. Cell. Infect. Microbiol.  vol 9: article 287 doi:10:3389/fcimb.2019.00287, 2019.

Takacs, C.N., Scott, M., Chang, Y. Kloos, Z.A., Irnov, I., Rosa, P.A., Liu, J., Jacobs-Wagner, C. A CRISPR interference platform for selective downregulation of gene expression in Borrelia burgdorferi. Appl. Environ. Microbiol. doi: 10.1128/AEM.02519-20, 2020.

Gomes-Solecki, M., Arnaboldi, P., Backenson, P.B., Benach, J.L., Cooper, C.L., Dattwyler, R.L., Diuk-Wasser, M., Fikrig, E., Hovius, J.W., Lagreid, W., Lundberg, U., Marconi, R.T., Marques, A.R., Molloy, P., Narasimhan, S., Pal, U., Pedra, J.H.F., Plotkin, S., Rock, D.L., Rosa, P., Telford, S.R., Tsao, J., Yang, X.F., and Schutzer, S.E.  Protective immunity and new vaccines for Lyme disease. Clin. Infect. Dis.70:1768-73, doi: 10.1093/cod/ciz872, 2020.

Wachter, J., Martens, C., Barbian, K., Rego, R., Rosa, P.A. Epigenomic landscape of Lyme disease spirochetes reveals novel motifs. mBio 12:e01288-21, doi: 10.1128/mBio.01288-21, 2021.

Bhatia, B., Hillman, C., Stewart, P., Rosa, P. Probing the role of bba30, a highly conserved gene of the Lyme disease spirochete, throughout the mouse-tick infectious cycle. Infect. Immun. 89:e00333-21,  doi: 10.1128/IAI.00333-21.

Visit PubMed for a complete publications listing.

Content last reviewed on